Research ArticleOriginal Research

Overnight Pulse Oximetry to Determine Prognostic Factors in Subjects With Amyotrophic Lateral Sclerosis

Silvia Martín Bote, Natalia Pascual Martinez, Cristina Esteban Amarilla, Pilar Font Ugalde, Jesús Gonzalez-Bermejo, Nuria Feu Collado and Bernabe Jurado Gamez
Respiratory Care August 2020, 65 (8) 1128-1134; DOI: https://doi.org/10.4187/respcare.07154

References

  1. 1.↵
    1. Chiò A,
    2. Mora G,
    3. Calvo A,
    4. Mazzini L,
    5. Bottacchi E,
    6. Mutani R
    ; PARALS. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology 2009;72(8):725-731.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Mandrioli J,
    2. Faglioni P,
    3. Merelli E,
    4. Sola P
    . The epidemiology of ALS in Modena, Italy. Neurology 2003;60(4):683-689.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Vender RL,
    2. Mauger D,
    3. Walsh S,
    4. Alam S,
    5. Simmons Z
    . Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival. Amyotroph Lateral Scler 2007;8(1):36-41.
    OpenUrlPubMed
  4. 4.↵
    1. Tsara V,
    2. Serasli E,
    3. Steiropoulos P,
    4. Tsorova A,
    5. Antoniadou M,
    6. Zisi P
    . Respiratory function in amyotrophic lateral sclerosis patients. The role of sleep studies. Hippokratia 2010;14(1):33-36.
    OpenUrlPubMed
  5. 5.↵
    1. Von Elm E,
    2. Altman DG,
    3. Egger M,
    4. Pocock SJ,
    5. Gotzsche PC,
    6. Vandenbroucke JP
    ; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335(7624):806-808.
    OpenUrlFREE Full Text
  6. 6.↵
    1. Arpa Gutiérrez J
    . Guide for attention of amyotorphic lateral sclerosis (ALS) in Spain. Ministry of Health and Social Policy. 2009. https://www.mscbs.gob.es/profesionales/prestacionesSanitarias/publicaciones/docs/esclerosisLA.pdf, Accessed March 17, 2019.
  7. 7.↵
    1. Barrera Chacón JM,
    2. Benítez Moya JM,
    3. Boceta Osuna J,
    4. Caballero Eraso C,
    5. Camino León R,
    6. Carraso Cárdenas V,
    7. et al
    . Document from consensus for the care of patientis with amyotrophic lateral sclerosis: 2017 update. Sevilla: Ministry of Health. http://www.elaandalucia.es/WP/wp-content/uploads/GUIA-ASISTENCIAL-ELA-revisión-2017.pdf, Accessed March 17, 2019.
  8. 8.↵
    Haute Autorité en Santé. High Authority in Health. Care of people with amyotrophic lateral sclerosis. 2006. http://www.has-sante.fr/upload/docs/application/pdf/Sclerose_laterale_amyotrophique_long.pdf. Accessed April 15, 2019.
  9. 9.↵
    1. Gonzalez-Bermejo J,
    2. Morelot-Panzini C,
    3. Arnol N,
    4. Meininger V,
    5. Kraoua S,
    6. Salachas F,
    7. Similowski T
    . Prognostic value of efficiently correcting nocturnal desaturations after one month of non-invasive ventilation in amyotrophic lateral sclerosis: a retrospective monocentre observational cohort study. Amyotroph Lateral Scler Frontotemporal Degener 2013;14(5-6):373-379.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Hardiman O
    . Management of respiratory symptoms in ALS. J Neurol 2011;258(3):359-365.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Ackrivo J,
    2. Hansen-Flaschen J,
    3. Wileyto EP,
    4. Schwab RJ,
    5. Elman L,
    6. Kawut SM
    . Development of a prognostic model of respiratory insufficiency or death in amyotrophic lateral sclerosis. Eur Respir J 2019;53(4). pii: 1802237
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Prell T,
    2. Ringer TM,
    3. Wullenkord K,
    4. Garrison P,
    5. Gunkel A,
    6. Stubendorff B,
    7. et al
    . Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation? J Neurol Neurosurg Psychiatry 2016;87(9):1022-1026.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Raymond J,
    2. Oskarsson B,
    3. Mehta P,
    4. Horton K
    . Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010–2015. Amyotroph Lateral Scler Frontotemporal Degener 2019;20(5-6):413-420.
    OpenUrl
  14. 14.↵
    1. Elman LB,
    2. Siderowf AD,
    3. McCluskey LF
    . Nocturnal oximetry: utility in the respiratory management of amyotrophic lateral sclerosis. Am J Phys Med Rehabil 2003;82(11):866-870.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Ambrosino N,
    2. Carpenè N,
    3. Gherardi M
    . Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J 2009;34(2):444-451.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Hutchinson D,
    2. Whyte K
    . Neuromuscular disease and respiratory failure. Pract Neurol 2008;8(4):229-237.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Piper AJ
    . Nocturnal hypoventilation - identifying & treating syndromes. Indian J Med Res 2010;131:350-365.
    OpenUrlPubMed
  18. 18.↵
    1. Gil J,
    2. Funalot B,
    3. Verschueren A,
    4. Danel-Brunaud V,
    5. Camu W,
    6. Vandenberghe N,
    7. et al
    . Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol 2008;15(11):1245-1251.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Pisa FE,
    2. Logroscino G,
    3. Giacomelli Battiston P,
    4. Barbone F
    . Hospitalizations due to respiratory failure in patients with Amyotrophic Lateral Sclerosis and their impact on survival: a population-based cohort study. BMC Pulm Med 2016;16(1):136.
    OpenUrl
  20. 20.↵
    1. Lechtzin N,
    2. Wiener CM,
    3. Clawson L,
    4. Chaudhry V,
    5. Diette GB
    . Hospitalization in amyotrophic lateral sclerosis: causes, costs, and outcomes. Neurology 2001;56(6):753-757.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Sanjuán-López P,
    2. Valiño-López P,
    3. Ricoy-Gabaldón J,
    4. Verea-Hernando H
    . Amyotrophic lateral sclerosis: impact of pulmonary follow-up and mechanical ventilation on survival. A study of 114 cases. Arch Bronconeumol 2014;50(12):509-513.
    OpenUrl
  22. 22.↵
    1. Tard C,
    2. Defebvre L,
    3. Moreau C,
    4. Devos D,
    5. Danel-Brunaud V
    . Clinical features of amyotrophic lateral sclerosis and their prognostic value. Rev Neurol (Paris) 2017;173(5):263-272.
    OpenUrl
  23. 23.↵
    1. Andersen PM,
    2. Abrahams S,
    3. Borasio GD,
    4. de Carvalho M,
    5. Chio A,
    6. et al
    EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force. Eur J Neurol 2012;19(3):360-375.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Vrijsen B,
    2. Testelmans D,
    3. Belge C,
    4. Robberecht W,
    5. Van Damme P,
    6. Buyse B
    . Non-invasive ventilation in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2013;14(2):85-95.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Georges M,
    2. Golmard JL,
    3. Llontop C,
    4. Shoukri A,
    5. Salachas F,
    6. Similowski T,
    7. et al
    . Initiation of non-invasive ventilation in amyotrophic lateral sclerosis and clinical practice guidelines: single-centre, retrospective, descriptive study in a national reference centre. Amyotroph Lateral Scler Frontotemporal Degener 2017;18(1-2):46-52.
    OpenUrl
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords